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CRYAB (aB-crystallin) is expressed inmany tissues and yet the R120Gmutation
in CRYAB causes tissue-specific pathologies, namely cardiomyopathy and catar-
act. Here, we present evidence to demonstrate that there is a specific functional
interaction of CRYABwith desmin intermediate filaments that predisposesmyo-
cytes to disease caused by the R120Gmutation. We use a variety of biochemical
and biophysical techniques to show that plant, animal and ascidian small heat-
shock proteins (sHSPs) can interact with intermediate filaments. Nevertheless,
the mutation R120G in CRYAB does specifically change that interaction
when compared with equivalent substitutions in HSP27 (R140G) and into the
Caenorhabditis elegans HSP16.2 (R95G). By transient transfection, we show that
R120G CRYAB specifically promotes intermediate filament aggregation in
MCF7 cells. The transient transfection of R120G CRYAB alone has no significant
effect upon cell viability, although bundling of the endogenous intermediate fila-
ment networkoccurs and themitochondria are concentrated into the perinuclear
region. The combination of R120G CRYAB co-transfected with wild-type
desmin, however, causes a significant reduction in cell viability. Therefore, we
suggest that while there is an innate ability of sHSPs to interact with and to
bind to intermediate filaments, it is the specific combination of desmin and
CRYAB that compromises cell viability and this is potentially the key to the
muscle pathology caused by the R120G CRYAB.
1. Introduction
The discovery that the R120G mutation in aB-crystallin (CRYAB, HSPB5 [1])
phenocopies desmin mutations [2,3] in human desmin-related myopathies
(DRMs) provided the first genetic evidence in support of the proposed func-
tional interaction between CRYAB and intermediate filaments [4]. Since that
discovery, there have been many studies on the mechanisms that cause DRM.
These have included the identification of the amyloid-forming potential of
CRYAB [5,6], the involvement of the proteosomal [7] and macroautophagy
pathways [8], as well as the propagation of apoptotic signals via desmin frag-
mentation [9] and the involvement of mitochondria [10]. Desmin is intimately
involved in mitochondrial positioning and homeostasis [11–15] and mitochon-
drial changes are a prominent associated phenotype in both DRM patients [16]
and mouse models of cardiomyopathy [17]. The caspase 6-mediated fragmenta-
tion of desmin produces an N-terminal fragment that promotes filament
aggregation [9]. Blocking this has been shown to attenuate another model of
& 2013 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.
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cardiomyopathy based on tumour necrosis factor-mediated
apoptosis [18]. Other mouse models of cardiomyopathy that
have not genetically targeted desmin or CRYAB expression
[19,20] see changes in desmin distribution and its inclusion
into aggregates and an association with CRYAB. The emerging
consensus is that the redistribution of desmin into aggregates
[21,22] is a key initiator in the pathology of DRMs.
Protein aggregates containing both desmin and CRYAB
were a feature of the description of the R120G CRYAB
family [1]. This was faithfully replicated in a knock-in mouse
model of the R120G CRYAB disease-causing mutation, with
desmin aggregation in muscles and the additional observation
of increased vimentin aggregation in the lenses of these
animals [23]. Cataracts were also noted in those family mem-
bers expressing R120G CRYAB [1]. These data could suggest
that the CRYAB interaction may not be specific to desmin, as
vimentin also associates with CRYAB [4]. Indeed, the co-
association of CRYAB with intermediate filament aggregates
is a common histopathological feature in the human diseases
caused by mutant cytoplasmic intermediate filament proteins
that form aggregates [24]. Therefore, it is important to examine
the specificity of the functional interaction between desmin
filaments and CRYAB if we are to understand fully the
muscle pathology caused by mutant CRYAB and desmin.
Previously, we have shown that small heat-shock proteins
(sHSPs) are important modulators of intermediate filament
assemblies [4]. They can prevent filament–filament interactions
from occuring on the basis of an in vitro-based viscosity assay
and transient transfection studies [25]. The R120G mutation in
CRYAB was found to abrogate this activity both for glial fibril-
lary acidic protein (GFAP) [25] and desmin filaments [26],
promoting instead filament–filament interactions and their
aggregation. Mutations in other sHSPs also cause human dis-
eases from cataract to distal neuropathies, which include
CRYAA (HSPB4), HSP27 (HSPB1), HSP27L (HSPB3; [27]) and
HSP22 (HSPB8) (summarized in [28]). Intermediate filament
aggregates feature in the histopathologies of such diseases,
demonstrating that the interaction between sHSPs and inter-
mediate filaments is a widespread and functionally important
interaction. The question to emerge from these studies is why
only certain cell types and tissues are affected by mutations in
an sHSP, whereas their tissue expression profile is not usually
restricted (except perhaps CRYAA [29]). CRYAB [30], HSP27
and HSP22 are all expressed in muscle [31–33], but mutations
in HSP27 and HSP22 are not associated with muscle pathology.
There have been many suggestions to explain the tissue-
specific pathologies associated with sHSP mutations [34–40],
butwepropose that the specific intermediate filament expression
pattern must be considered as a key factor in any sHSP-based
pathology as we consider the intermediate filament–sHSP com-
plex to be a functional unit [41,42]. Intermediate filament
expression profiles follow tissue-specific patterns according to
embryological origins [43]. It has already been shown that
R120G CRYAB induces the aggregation of desmin filaments
[26], but it can also potentially cause the aggregation of GFAP
filaments [25]. The reported pathologies for CRYAB mutations
are, however, myopathies and cataract and not neuropathies.
Desmin is a type III intermediate filament protein expressed in
muscle, which suggests that the interaction of desmin with
CRYAB is key to understanding DRM.
To test this hypothesis, we considered the consequences
of introducing CRYAB R120G equivalent mutations into
other sHSPs, such as HSP27 and HSP16.2, to see if equivalent
mutations would also change their interaction with desmin.
The R120G mutation in the a-crystallin domain of CRYAB
is predicted to have similar structural consequences for
HSP27 [44], and therefore for both HSP27 and CRYAB the
equivalent mutation should have similar effects. We find
that only the R120G CRYAB mutation induces increased
binding to desmin as assessed by in vitro sedimentation
assay. We assessed the interaction of desmin and CRYAB
using a range of in vitro techniques (falling ball assay,
Ostwald viscometry, surface plasmon resonance (SPR) and
optical trap measurement of filament network elasticity) to
evidence the interaction of CRYAB with desmin. We show
that the binding of CRYAB to desmin is pH- and cation-
dependent. Using transient transfection, we show that only
the desmin-CRYAB R120G combination-induced desmin
aggregates coincided with reduced cell viability in MCF7
cells. We suggest that it is the partnership of the sHSP with
the resident intermediate filaments that determines how
cells respond to the presence of mutant CRYAB.
2. Material and methods
(a) Expression constructs for recombinant sHSPs
Wild-type (WT) or R120G CRYAB expression vectors based on
the pET23b plasmid were constructed as described previously
[25]. HSP27 and R140G HSP27 were constructed as described
[45]. The Caenorhabditis elegans HSP16.2 cDNA was cloned into
the pRSET expression vector (Invitrogen) as described previously
[46] using the QuickChange site-directed mutagenesis kit (Strata-
gene) to introduce the R95G mutation into WT HSP16.2. For live
cell imaging experiments, CRYAB or desmin were subcloned
into the modified pcDNA3.1 (þ) vector with DsRed2-Mito
(Clontech) preceded by an internal ribosomal entry site (IRES).
These two vector components were PCR amplified from the vec-
tors DsRed2-Mito (Clontech) and pWPI (http://tronolab.epfl.ch)
and sequenced in pGEM-T Easy (Promega, UK) before assem-
bling with the relevant CRYAB or desmin fragments from the
pET23. These IRES-containing bicistronic vectors allow simul-
taneous expression of both mitochondrially targeted red
fluorescent protein to indicate transfected cells and either
CRYAB or desmin constructs.
(b) Expression and purification of recombinant
wild-type and mutant sHSPs
Both WT and mutant sHSPs were expressed in and purified from
BL21(DE3) pLysS Escherichia coli as described. WT and R120G
CRYAB were purified as described using two diethylaminoetha-
nol (DEAE) column steps at 48C [25]. Recombinant human WT
and R140G HSP27 were purified using similar procedures. For
further studies, purified sHSPs were refolded by dialysis against
20 mM Tris–HCl, pH 7.4, 100 mM NaCl at 48C for 16 h.
Both the WT and R95G HSP16.2 formed inclusion bodies,
which were purified [47] and then solubilized in TEN buffer
containing 8 M urea. Purification required anion exchange
chromatography using DEAE-cellulose (DE52; Whatman, UK)
in the presence of 6 M urea. Peak fractions were pooled and then
dialysed against buffer containing 20 mM Tris–HCl, pH 7.4,
100 mM NaCl. The native complex was further purified by size
exclusion chromatography (SEC) on a Fractogel EMD BioSEC
Superformance column (60  1.6 cm; Merck, UK) in the same
buffer. Purified proteins were concentrated to 1 mg ml21 using
Ultrafree-15 (Millipore, UK) concentrators with a 10 kDa
molecular weight cut-off.
rstb.royalsocietypublishing.org
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(c) Preparation of desmin, glial fibrillary acidic protein
and keratins
Purified desmin was obtained by extraction of the crude
intermediate filament preparation from chicken gizzards with
8 M urea and the subsequent chromatography on DEAE-
cellulose and hydroxyapitite columns in the presence of 6 M
urea as described previously [48,49]. Recombinant human
desmin, GFAP, keratins 7 and 18 were purified as described
[4,26,50,51]. Protein concentrations were determined by the
bicinchonic acid assay (BCA reagent, Pierce) using bovine
serum albumin as standard.
(d) Size exclusion chromatography of sHSPs
Molecular size of the recombinant sHSP complexes were measured
by gel filtration chromatography on a Superformance column (60 
1.6 cm) packed with Fractogel EMD BioSEC (Merck, UK). The
column was calibrated using thyroglobulin (669 kDa), apoferritin
(440 kDa), alpha-amylase (200 kDa), bovine serum albumin
(67 kDa) and carbonic anhydrase (29 kDa). The column void
volume was determined using dextran blue (2000 kDa). Proteins
were eluted in buffer containing 20 mM Tris–HCl, pH 7.4 and
100 mM NaCl at room temperature and the elution volume of
each sample was used to estimate the molecular weight.
(e) Intermediate filament assembly, binding and
viscosity assays involving sHSPs
Low-speed and high-speed sedimentation assays were used to
assess the ability of sHSPs to associate with intermediate fila-
ments and prevent filament–filament associations that lead to
aggregation [52]. Intermediate filament proteins were mixed
with sHSPs in urea buffer (8 M urea, 20 mM Tris–HCl, pH 8.0,
5 mM EDTA, 2 mM EGTA, 1 mM DTT) and then dialysed to
lower the urea concentration stepwise into low ionic strength
buffer (10 mM Tris–HCl pH 7.0, 1 mM DTT) at 48C. Sometimes
CRYAB was added at this stage prior to initiating filament
assembly by dialysis into filament assembly buffer (10 mM
Tris–HCl pH 7.0, 1 mM DTT 50 mM NaCl) at room temperature
for 12 h. Assembly of desmin and GFAP filaments was also
initiated by the addition of a 20-fold concentrated binding
buffer to low ionic strength buffer, giving a final concentration
of 100 mM imidazole-HCl, pH 6.8, 1 mM DTT. Protein samples
were incubated for 2 h at the indicated temperatures. Exper-
iments to investigate pH and temperature effects on CRYAB
associations were carried out as follows with WT GFAP, vimen-
tin and desmin assembled at 0.2 mg ml21 and mixed with WT
CRYAB at a 1 : 1 molar ratio. Filament assembly was completed
by dialysis into 20 mM N-2-hydroxyethylpiperazine-N-2-ethane-
sulfonic acid (HEPES), 100 mM NaCl, 1 mM MgCl2, 1 mM DTT
at pH 6.3, 6.8 or 7.3; at 238C, 398C or 448C, respectively. In
some instances, CRYAB was also added to assembled filaments.
The influence of sHSPs on filament–filament interactions of
assembled desmin was assessed also by measuring the visco-
elastic properties. First, we used a falling ball assay as
described previously [51]. The ability of the sample to support
a ball bearing was then scored in a binary fashion. Carbonic
anhydrase (Sigma, UK) was used as a control. We performed
viscosity measurements using an Ostwald-type viscometer
(Cannon, USA) at a protein concentration of 0.5 mg ml21 at
378C. GFAP was assembled in the absence or the presence of
CRYAB by addition of a 20-fold binding buffer as described
above. Flow times were measured at different time points:
1 min after assembly start and then every 5 min over a period
of 1 h. Specific viscosity (Vsp) was calculated by the equation
Vsp ¼ (Ts2 Tb)/Tb, where Ts is the flow time of the sample
and Tb the flow time of the buffer.
( f ) Passive microrheology measurements
Desmin filaments were assembled from purified recombinant
protein at 1 mg ml21 with or without a 1 : 10 molar ratio of
desmin : CRYAB using dialysis to lower the urea concentration.
Assembly was completed by overnight dialysis into 20 mM
Tris–HCl (pH 7.3), 50 mM NaCl, 1 mM MgCl2 and 1 mM DTT
at room temperature. One-particle passive microrheology was
done using a 808 nm laser and a 100 oil objective (NA 1.4)
on an inverted Nikon phase microscope. PLL-coated polystyrene
beads of 1.5 mm were trapped, laser light was collected using an
oil condenser, and the intensity fluctuations were recorded using
a quadrant photodiode (QPD). With a custom-written program
in Cþþ, the apparent elastic modulus G0app and apparent vis-
cous modulus G00app were determined from the fluctuations in
bead position using the fluctuation–dissipation theorem and
generalized Stokes–Einstein equation [53]. The viscous modulus
was calculated from G00app by subtracting the solvent viscosity,
and the elastic modulus was calculated from G0app by subtracting
the apparent modulus in buffer to compensate for the presence of
the optical trap [54].
(g) Binding of CRYAB and R120G CRYAB measured by
surface plasmon resonance
Affinities of WT or R120G CRYAB to immobilized intermediate
filament proteins were determined using SPR analysis with a
Biacore 3000 apparatus (GE Healthcare, Uppsala, Sweden). Pur-
ified desmin, GFAP and vimentin were immobilized on the
dextran matrix of a CM5 sensor chip according to the manufac-
turer’s instructions using 10 mM HEPES, pH 7.4, 0.15 M NaCl,
3.4 mM EDTA, 0.005 % (v/v) surfactant P20. Unreacted groups
were subsequently blocked by injection of 1 M ethanolamine,
pH 8.5. WT and R120G CRYAB for binding to immobilized inter-
mediate filament proteins were first diluted to 20 gml–1, injected
at a flow rate of 5 l min21 for 7 min at 378C and then washed for
7 min. All sensograms were corrected for non-specific inter-
actions to a reference surface and by double referencing [55].
The sensor chip was regenerated between injections by washing
with 6 M guanidine hydrochloride in HBS-EP buffer.
(h) Cell cultures, transient transfection and cell viability
assays
The immortalized human lens epithelial cell line H36CE2 was
grown as detailed previously [56]. Baby hamster kidney
(BHK21) cells, mouse myoblast C2C12 cells and human breast
cancer epithelial cell MCF7 were grown in media as rec-
ommended by the ECACC (www.ecacc.org.uk). For co-
transfection experiments, plasmid DNA (pcDNA3.1; Invitrogen,
UK) containing human desmin, CRYAB, HSP27 or HSP16.2 in
pcDNA3.1 (Invitrogen, UK) were prepared using MaxiPrep kits
(Qiagen, UK). H36CE2 cells were transiently co-transfected by
calcium phosphate precipitation using standard procedures
[57], while GeneJuice Transfection Reagent (Merck Millipore,
UK) was used to transiently transfect the other cell lines. Cells
were allowed to recover for 24–48 h prior to processing for
immunofluorescence microscopy as described previously [58].
Quantification of the desmin filament phenotypes was per-
formed by visual assessment of various staining patterns in
transfected cells. For each DNA construct, cells on three cover-
slips were counted and approximately 100–150 transfected
cells were assessed per coverslip. For cell viability assay, the col-
orimetric CellTiter 96 AQueous One Solution Cell Proliferation
Assay (Promega, UK) was used according to the manufacturer’s
instructions. Statistical significance was analysed by one-way
ANOVA and the level of significance was set at p  0.05. Apop-
totic cells were assessed by staining with a monoclonal antibody
rstb.royalsocietypublishing.org
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M30 (1 : 10, Roche Diagnostics, Mannheim, Germany) that
specifically recognizes a neo-epitope of keratin 18 fragment gen-
erated by caspase cleavage at position Asp396 and counterstained
with 5 mg ml21 DAPI (Molecular Probe Inc., Eugene, OR, USA).
(i) Primary antibodies
The primary antibodies used in this study were rabbit polyclonal
anti-desmin (1 : 100; Sigma, UK), desmin monoclonal (D3; Develop-
mental Biology Hybridoma Service), mouse monoclonal anti-
HSP27 (1 : 100; [59]), mouse monoclonal anti-CRYAB (1 : 1; [60])
or mouse polyclonal anti-HSP16.2 (1 : 50; [46]). Desmin (PDE;
Euro-Diagnostica, The Netherlands) and mouse monoclonal
anti-desmin (D33; DakoCytomation), keratin (LE41; mouse mono-
clonal) and GFAP (polyclonal 3270 and monoclonal GA5) were
as described [58]. After washing with PBS/BSA/azide, the primary
antibodies were detected using FITC (1 : 100; Sigma, UK), Texas-
Red (1 : 200; Jackson ImmunoResearch Laboratories, UK) or Alexa
594 (1 : 500; Molecular Probe, UK) conjugated secondary antibodies.
( j) Preparation of cell lysates and immunoblotting
analysis
Cells plated at a density of 1  106 cells per 100mm Petri dish
were transfected with expression vectors as indicated. After
48 h, cell lysates were prepared [26] and analysed by immuno-
blotting followed by enhanced chemiluminescence using a
luminescent image analyser (LAS-1000plus; FujiFilm, Japan).
(k) Live cell imaging and movie preparation
For live cell imaging, cells transfected with pcDNA3.1-IRES-
DsRED2-Mito vectors were cultured in standard culture
medium containing 10 mM HEPES, pH 7.0. in glass-bottomed
culture dishes (Iwaki) and maintained at 378C in a humidified
chamber. At 24 h after transfection, time-lapse images were
acquired in an Axiovert 200 inverted microscope equipped
with a charge-coupled device camera (AxioCam; Carl Zeiss,
Jena, Germany) using the AxioVision (Carl Zeiss, Jena,
Germany) software. Real-time images were acquired every
10 min for 12 h using a standard Rhodamine filter set (excitation
at 550 nm and emission at 590–650 nm) at 40 magnification.
Short exposure time and a neutral density filter were used
during image acquisition to minimize photobleaching and
phototoxicity. Digitized images were imported into QUICKTIME
Software (QUICKTIME v. 5.0; Apple, Cupertino, CA, USA) and
converted into movies.
3. Results and discussion
(a) Determination of oligomeric sizes of wild-type and
mutant sHSPs
Previous studies showed that the R120G mutation in CRYAB
altered its secondary, tertiary and quaternary structure [25].
To extend these findings, the corresponding mutations in
human HSP27 (R140G) and in C. elegans HSP16.2 (R95G)
were generated by site-directed mutagenesis and compared
with R120G CRYAB by SEC. WT CRYAB (figure 1a) and
HSP27 (figure 1b) eluted at positions corresponding to aver-
age molecular sizes of approximately 520 and 560 kDa,
respectively (table 1), which is consistent with previous pub-
lished results [25,61]. The arginine mutation significantly
altered the molecular masses of R120G CRYAB and R140G
HSP27 (figure 1a and table 1), but with opposite conse-
quences. R140G HSP27 formed a polydisperse population
of protein oligomers ranging in size from over 600 kDa to
approximately 50 kDa (figure 1b), which was smaller than
the WT HSP27. R120G CRYAB on the other hand was
larger (684 kDa) than the WT CRYAB and also appeared no
more polydisperse than the WT. There was no major effect
R120G CRYAB
WT CRYAB
(kDa)(a) VO0.05
0.04
0.03
A
28
0
0.02
0.01
0 20 40 60
time (min)
(c)
R140G HSP27
WT HSP27
669 443 150 (kDa)66
A
28
0
0.05
0.06
0.04
0.03
0.02
0.01
0 50 100 150
time (min)
80 100 120
150443669
R95G HSP16.2
WT HSP16.2
443669 200 (kDa)VO
(b) 0.03
A
28
0 0.02
0.01
0 20 40 60
time (min)
80 100 120
Figure 1. Analysis of oligomeric sizes of WT and mutant sHSPs. SEC was performed using a Superformance column as described in §2d. The elution profiles of WT
and mutant (a) CRYAB, (b) HSP27 and (c) HSP16.2 are shown and represent an average of three independent experiments. Elution positions of molecular weight
protein standards and their corresponding sizes are indicated on the top of each panel (downward arrows). The position of void volume (Vo) was determined using
blue dextran. (Online version in colour.)
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upon the assembly of the oligomeric complexes of HSP16.2
when the equivalent arginine residue (R95) was mutated
(figure 1c). The R95G mutant eluted with almost the same
elution volume as that of WT HSP16.2 with an apparent mol-
ecular mass of approximately 580 kDa (figure 1c and table 1).
The three mutants therefore cover the range of potential con-
sequences for the quaternary structure of sHSPs after the
introduction of a glycine residue instead of arginine at this
conserved site, by either reducing or increasing the oligomer
size or producing no apparent change.
(b) Effect of the sHSP arginine mutations upon their co-
sedimentation with intermediate filaments and
preventing filament– filament associations
Several in vitro assays have been developed to study the effect
of the R120G mutation on the interaction of CRYAB with
intermediate filaments. These include the ability of sHSPs
to co-sediment with intermediate filaments and to prevent
filament–filament interactions as detected by falling ball vis-
cometry [51]. Vimentin and GFAP, but not desmin, have been
tested in the falling ball assay. Desmin is the physiological
target for CRYAB in muscle as revealed by the phenocopying
of the disease, desmin-related myopathy, by both desmin and
CRYAB mutations [1].
In vitro intermediate filament co-sedimentation assays
were conducted using optimized pH and salt conditions
[26]. Under these conditions, desmin was assembled and
sedimented efficiently as shown by the proportion of
the protein partitioning into the pellet fraction in the control
(figure 2a). Both the WT and R120G CRYAB (figure 2a) bind
to desmin filaments in a temperature-dependent manner. The
increased co-sedimentation of R120G CRYAB with desmin
filaments compared with WT protein (figure 2a) was appar-
ent at all three temperatures. Even at 378C, almost all of the
R120G CRYAB was found to bind to pelletable desmin fila-
ments, whereas the binding of WT protein to desmin was
incomplete with a small proportion still remaining in the
supernatant fractions (figure 2a). For the experiments pre-
sented in figure 2a, a 1 : 1 molar ratio of desmin : CRYAB
was used, although similar results were obtained with
decreasing molar ratios at 1 : 0.5, 1 : 0.2 and 1 : 0.1 (data not
shown). The binding of HSP27 to desmin filaments (figure
2b) was apparently less efficient than HSP16.2 (figure 2c)
and CRYAB (figure 2a). When included at a 1 : 1 molar
ratio, the WT HSP27 showed limited binding to desmin fila-
ments with co-sedimentation being greatest at 448C (figure
2b). The co-sedimentation of R140G HSP27 to desmin fila-
ments can be detected at 228C and this remained unaltered
at elevated temperatures (figure 2b). The R140G HSP27
appeared to co-sediment more efficiently with desmin fila-
ments than WT HSP27.
In contrast to both CRYAB and HSP27, WT HSP16.2 only
partially co-sedimented with desmin filaments (figure 2c). We
selected this particular sHSP as a representative of those
expressed in the animal C. elegans. It is a stress-induced sHSP
in this animal and multimerization is important to its function
[62]. There are also cytoplasmic intermediate filaments in
C. elegans, albeit quite different in primary sequence to mamma-
lian desmin [63]. The co-sedimentation of HSP16.2 appeared to
be independent of temperature, as the WT protein was similarly
distributed between supernatant (S) and pellet (P) fractions
irrespective of temperature. Similar results were obtained for
R95G HSP16.2 (figure 2c). Therefore, for this mutant, minimal
effect upon the quaternary structure of the protein coincided
with little change in the co-sedimentation properties with
desmin filaments.
Of the three sHSPs and their respective arginine mutants, it
was the R120G CRYAB that was most affected. We therefore
considered whether this would alter the co-sedimentation of
CRYAB with in vitro assembled keratin filaments (figure 2d).
Filaments of keratins 7 and 18 also co-sedimented with WT
CRYAB and co-sedimentation was significantly increased by
the R120G CRYAB mutation, mimicking the results obtained
with desmin. These data suggest that the increased co-sedi-
mentation of CRYAB R120G is not necessarily restricted to
desmin, but includes other type III intermediate filaments, in
particular vimentin and GFAP, and also keratins (this study).
To assess the possible function of these various sHSPs and
their arginine mutants, an assay to measure the effect of sHSPs
upon filament–filament interactions was developed [51]. This
assay is based upon falling ball viscometry, which provides a
measure of sHSP-desmin interactions at equilibrium. Desmin
filaments form a gel capable of supporting the metal ball
used in the assay. The effect of the arginine mutations upon
the chaperone activity of sHSP was tested. Previous studies
showed that the addition of sHSPs, including CRYAB and
HSP25, to assembling intermediate filament solutions pre-
vented gel formation and so permitted the ball to sink to the
bottom of the tube, even though filament assembly was not
inhibited [51]. As expected, after the assembly of desmin, a
gel formed preventing the ball from falling to the bottom of
the tube. The presence of WT human CRYAB, C. elegans
HSP16.2 and HSP27 with desmin allowed the ball bearing to
sink to the bottom of the capillary (table 2). These WT
sHSPs are apparently very effective at preventing gel for-
mation over a 10-fold concentration range (table 2). The
R95G mutation did not abolish the activity of HSP16.2 in
this assay. In contrast, the mutant R120G CRYAB appeared
completely ineffective at inhibiting gel formation, the ball
remaining on top of the assembled desmin sample in the capil-
lary. HSP27 R140G was equally effective as the WT protein at
1 : 1 ratios, but was ineffective at the 0.2 : 1 ratio, in contrast to
the WT HSP27 (table 2).
This assay provides a rapid way to assess the potential
activity of different intermediate filament and sHSP combi-
nations. In table 3, we provide additional evidence that
Table 1. SEC analysis of sHSP oligomers.
molecular massesa of WT sHSPs and their mutants
WT/mutant sHSP apparent Mr(kDa)
WT HSP16.2 572 + 72
R95G HSP16.2 584 + 80
WT aB-crystallin 520 + 84
R120G aB-crystallin 684 + 78
WT HSP27 560 + 74
R140G HSP27 150 + 242
aMolecular masses (M) were determined from a plot of logM versus Ve/Vo
of molecular mass standards.
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sHSPs from evolutionary-unrelated organisms appear to
have an innate ability to affect desmin gel formation in this
falling bead assay. As an extreme test of this concept, the
chloroplast-specific sHSP, HSP21 [64], was found to be able
to prevent desmin gel formation. It was therefore surprising
that another potential desmin-interacting mammalian sHSP,
HSP20, is not equivalent to CRYAB in this assay. HSP20 is
involved in cardioprotection and can also coassemble with
both HSP27 and CRYAB [65,66]. These data suggest that
while sHSPs from distant organisms can affect gel formation,
the different mammalian sHSPs do not possess completely
equivalent properties.
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Figure 2. Co-sedimentation of WT and arginine mutant sHSPs to desmin filaments in vitro. In this binding assay, the assembly was conducted at temperatures indicated
above the relevant gel tracks (a– c). The pellet (P) and supernatant (S) fractions from the co-sedimentation assays were analysed by SDS-PAGE and visualized by
Coomassie Blue staining. The positions of desmin (a– c), keratin (d ), WT and arginine mutants of CRYAB (a,d ) HSP27 (b) and Hsp16.2 (c) are indicated (arrows).
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(c) Measuring CRYAB interactions with type III
intermediate filament proteins using non-
equilibrium and equilibrium methods
SPR provides an equilibrium method to assess the relative
binding of WT and R120G CRYAB to desmin, GFAP and
vimentin (figure 3a). It can be seen that both WT and
R120G CRYAB had a greater capacity for binding desmin
than the other type III intermediate filament proteins, vimen-
tin or GFAP. Moreover, there was a significant increase in the
binding of R120G CRYAB to all three type III intermediate
filament proteins. These data support the interpretation that
there is selectivity in CRYAB binding to type III intermediate
filament proteins and that the R120G mutation increases the
binding of CRYAB to intermediate filaments supporting the
in vitro co-sedimentation data and electron microscopy data
[25,26]. More detailed interpretation of these data is compli-
cated by the uncertainty over which intermediate filament
assembly form is bound to the chip surface given that, at
20 mg ml21, both desmin [67] and vimentin [68,69] have the
potential to form filaments while this is likely not the case
for GFAP, which has a critical concentration of 80 mg ml21
[70]. Purging the chip with 6 M guanidine hydrochloride
should ensure that only intermediate filament monomers
are bound to the chip surface. On-chip association of
subunits, however, is a possibility once binding-buffer con-
ditions are restored. Furthermore, the inherent polydispersity
of CRYAB [71] further complicates the interpretation as it is
not known whether there is any selectivity by specific
CRYAB oligomers for intermediate filaments. SPR has been
used to study CRYAB subunit dynamics [72] and to assess
the relative affinity of different client proteins [73]. These
data confirm the preference of CRYAB for desmin and, from
the dissociation kinetics, it is clear that once bound, CRYAB
dissociates slowly from all three type III intermediate filament
proteins. This would fit the conclusion that there is a high affi-
nity binding site for CRYAB clients [74] and that topologically
distinct sites are present on CRYAB [75] for these different cli-
ents as born out by peptide array studies [76]. With respect to a
protein polymer such as an intermediate filament, the rules for
client selection by sHSPs may not parallel those established
for monomeric, destabilized clients such as T4 lysozyme
[75,77]. Indeed there is no evidence currently to suggest that
intermediate filament proteins naturally adopt unfolded con-
formations within the filament, although this can be induced
by mechanical stretching [78]. There is, however, evidence to
suggest that filaments exhibit different subunit geometries
that can be differentially detected by antibodies [79,80]
and could be induced by post-translational modifications
[19,81–87]. The presence of disease-causing mutants or
GFP-tagged intermediate proteins is sufficient to increase the
binding of CRYAB to the filaments [58,88], which we interpret
as evidence of altered subunit geometries inducing sHSP
association with intermediate filaments.
Using Ostwald viscometry, the assembly of GFAP in the
presence of WT and R120G CRYAB was analysed (figure 3b).
Addition of CRYAB reduced the overall viscosity of the
solution, but the presence of the R120G CRYAB induced a
catrastrophic loss of viscosity after approximately 25 min
when aggregates were visible in the solution consistent with
the falling ball assay. We confirmed the presence of highly
bundled filaments by electron microscopy (see the electronic
supplementary material, figure S1). These data indicate the abil-
ity of WT CRYAB to reduce the apparent viscosity of a solution
of GFAP filaments. In contrast, the presence of R120G CRYAB
promotes interactions between GFAP filaments, which induces
clumping and their eventual aggregation, which has the effect
of significantly reducing solution viscosity, but by a completely
different mechanism and with greater impact than the viscosity
reduction induced by WT CRYAB. The effect of the R120G
mutation is to drive the aggregation of the GFAP filaments.
A disadvantage of the Ostwald viscometer is that flow-
induced filament orientation occurs during the measure-
ments, which may lead to shear-thinning. For this reason,
we turned to a passive rheology approach using optically
trapped beads (figure 3c). As intermediate filaments are
semi-flexible polymers that show both elastic and viscous
Table 3. Effect of WT and mutant sHSPs on the gel formation by desmin
ﬁlaments as monitored by the falling ball assay. Inter-ﬁlament interactions
between assembled desmin ﬁlaments lead to the formation of a protein
gel that is capable of supporting a small stainless steel ball. Addition of
sHSPs in a molar ratio of 1 : 1 to desmin prevented this gel formation, thus
allowing the ball to drop to the bottom of the capillary tube. Carbonic
anhydrase was used as a control in these experiments.
sHSPs added to desmin solution ball position
no addition top
carbonic anhydrase top
CRYAB (HSPB5) bottom
HSP21 (Arabidopsis thaliana) bottom
HSP20 (HSPB6) top
Table 2. Summary of the data collected for the effect of sHSPs and their
arginine mutants on the gel formation by desmin ﬁlaments as monitored
by the falling ball assay. Desmin can form a protein gel capable of
supporting a small stainless steel ball. Addition of WT sHSPs in a range of
molar ratios from 1 : 1 to 0.1 : 1 to desmin allow ﬁlament assembly but
then prevent gel formation. In this case, the ball will descend easily into
the bottom of the capillary tube. A similar result was obtained for R95G
HSP16.2. The R120G CRYAB abrogated this activity of aB-crystallin even
over a 10-fold concentration range. The inhibitory effect of R140G HSP27
on gel formation is compromised, but not completely abolished, as this
mutant can still prevent gel formation when added at a 1 : 1 molar ratio.
WT and mutant sHSPs
added to assay
desmin gel formation as
indicated by the ball position
sHSP : desmin
(molar ratio) 1 : 1 0.2 : 1 0.1 : 1
WT CRYAB bottom bottom bottom
R120G CRYAB top top top
WT HSP27 bottom bottom bottom
R140G HSP27 bottom top top
WT HSP16.2 bottom bottom bottom
R95G HSP16.2 bottom bottom bottom
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properties, bulk rheology has been used to assess the mech-
anical properties of desmin networks in terms of their
flexibility and persistence lengths [89]. We find that CRYAB
slightly reduces the elastic modulus of the desmin filament
networks as measured by one-particle passive microrheology
(figure 3c). This confirms the interaction of CRYAB with
intermediate filaments, eliciting a measurable change in the
biomechanical properties of the filament solution. The diva-
lent cation-mediated interaction of C-terminal sequences of
the type III intermediate filament proteins could partly
explain the filament solution properties [90] and parallels
the similar role for the C-terminal extensions in neurofila-
ments [91]. The precise details of how CRYAB might
prevent the filament–filament interactions as measured by
the falling ball (table 2; [51]), low-speed sedimentation
[26,52] and viscosity assays (figure 3b) is not yet determined
and neither is the question of how this relates to the observed
reduction in the stiffness of the desmin filament network.
Nevertheless, for other poly-electrolyte systems such as
actin [92] and neurofilaments [91,93], the cations and pH in
solution and the amino acid sequence exposed at the filament
surface are known to be key factors in driving gel formation,
sHSP association and thus sample stiffness.
(d) Temperature and pH dependency of the interaction
of CRYAB with desmin, GFAP and vimentin
intermediate filaments
Desmin, GFAP and vimentin were assembled in vitro at three
different pH values and temperatures to see how these vari-
ables influenced CRYAB association. Previous studies with
recombinant purified human intermediate filament proteins
have looked at temperature effects (e.g. [67]), but not pH
effects, although the CRYAB association with a mixture of
desmin and actin at different pHs was investigated previously
[94]. Intermediate filaments were formed at all pHs and temp-
eratures analysed (figure 4e,f; data not shown for GFAP and
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Figure 3. Equilibrium methods of detecting the interaction of CRYAB with intermediate filaments. (a) Binding kinetics of WT and R120G CRYAB to different inter-
mediate filament (IF) proteins as measured by SPR. Desmin, GFAP and vimentin were immobilized to the dextran matrix of a CM5 sensor chip. Binding of 20 g ml
WT (a) or R120G (b) CRYAB to immobilized IF proteins were monitored at 378C for 7.5 min, followed by washing for 7.5 min. Measurements were performed at a
flow rate of 5 l min–1 using a Biacore 3000 Biosensor. Resonance measured during 900 s of exposure is plotted on the ordinate in arbitrary units. (b) Viscometric
analyses of GFAP assembly in the absence or presence of CRYAB. GFAP (0.5 mg ml21) was assembled either alone or coassembled with either WT or R120G CRYAB
in a molar ratio of 1 : 2 at 378C. Assembly was initiated at the 10 min time-point by addition of a 20-fold concentrated assembly buffer. Specific viscosity was
measured 1 min after assembly and then at 5 min intervals for 60 min. The profile obtained for GFAP reflects the normal increase of specific viscosity after initiation
of filament assembly. In the presence of WT CRYAB, GFAP exhibited a slightly decreased specific viscosity over a period of 40–45 min before reaching a plateau. In
contrast, for GFAP assembled in the presence of R120G CRYAB, the specific viscosity increased normally only during the first 25 min. Afterward it decreased dra-
matically, indicative of GFAP filament aggregation. (c) Passive rheology measurements by one-particle microrheology. WT desmin was assembled alone or with a
1 : 10 molar ratio of WT desmin: WT CRYAB. The position fluctuations of beads immersed in the network were measured by trapping beads with a weak 808 nm
laser and measuring scattered light on a QPD. The elastic modulus was corrected for the presence of the optical trap. Average G’ values (Pa) +1 s.d. from five
independently trapped beads for WT desmin and from 10 independently trapped beads for WT desmin with WT CRYAB are plotted against frequency (Hz). Desmin
assembled alone has a higher stiffness compared with when WT CRYAB is present. This difference is statistically significant with p  0.01, using a type 2, one-tailed
Student’s t-test. (Online version in colour.)
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vimentin). Desmin filaments were coated with CRYAB par-
ticles at pH 6.3 and at 238C (figure 4e,f). High-speed co-
sedimentation analyses showed that at pH 6.3 and over the
temperature range from 398C to 448C, more than 35 per cent
of the total CRYAB was associated with the desmin and
GFAP filaments. In line with the SPR data, CRYAB binding
followed the same trend, with desmin binding the most and
vimentin the least (figure 4a–c) at the temperatures and pHs
investigated. Lower binding was observed at pH 7.3 and 6.8
(figure 4a–c) indicating that there was a pH dependency in
CRYAB binding to desmin, GFAP and vimentin. We also
investigated the pH effects on the binding of CRYAB to pre-
formed GFAP filaments by co-sedimentation and observed a
similar trend of increased binding at pH 6.3 that was also
temperature-dependent (data not shown). Similar studies
were not possible for desmin, as in the absence of CRYAB
desmin filaments were attracted to the plastic surfaces of tips
and tubes (data not shown).
Ischaemia results in a pH decline in muscle tissue [95] and
the translocation to the Z- and I-bands of resident sHSPs [96,97],
which is the location of the desmin intermediate filaments.
Therefore, the data we have presented evidence the importance
of pH changes to the interaction of CRYAB with desmin. The
structure of CRYAB would be expected to change in acidosis,
resulting in a dimer-monomer transition of the a-crystallin
domain [98,99] as well as its activation [100]. The R120G
mutation in CRYAB, in contrast, stabilized its dimers at low
pH [101], the result of removal of a positive charge from
within the dimer interface which contains histidines sensitive
to physiological pH changes [44,98]. Therefore, it appears that
acidic pH can induce the release of monomeric WT CRYAB,
but not the R120G mutant. This perhaps leads to extended
interactions with desmin filaments, compared with WT
CRYAB, at physiological pH values as evidenced by the studies
here and those previously published [25,26,102].
(e) Transient transfection studies
In order to determine the effect of these arginine mutations
upon the potential in vivo activity of the respective sHSPs, tran-
sient transfection assays were performed. Desmin filaments
form characteristic aggregates as part of the histopathology
in the cardiomyopathies so far described with the R120G
CRYAB mutation. As a mimic of this situation, desmin was
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Figure 4. CRYAB interaction with desmin is divalent cation-, pH- and temperature-dependent. Binding of CRYAB to desmin, GFAP and vimentin filaments was
assessed by high-speed co-sedimentation assay (a–d ). The quantified results are presented as the mean+ s.d. of the percentage of CRYAB that had
co-sedimented with WT desmin, GFAP and vimentin at 238C, 398C and 448C (a– c, respectively). Note, most binding occurs at pH 6.3 and at 398C and 448C
with a preference for desmin over vimentin and GFAP. A representative gel image used for the quantification of binding to desmin is shown (d ). Three independent
experiments were used for the quantifications. (e,f ) WT desmin formed filaments of a few micrometres in length and had a much higher density of CRYAB particles
(arrow) surrounding the filaments at pH 6.3 (e) compared with pH 7.3 ( f ). Images are taken at the same magnification. Scale bar, 500 nm. G, GFAP; V, vimentin; D,
desmin; S, supernatant; P, pellet.
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Figure 5. Expression of R120G CRYAB induces the aggregation of intermediate filaments. (a– c) The immortalized human lens epithelial cell line H36CE2 was
transiently transfected with combinations of desmin with either WT CRYAB or R120G CRYAB (a), with desmin and either WT HSP27 or R140G HSP27 (b) and
with desmin and either WT HSP16.2 or R95G HSP16.2 (c). The number of desmin aggregate-containing cells were then counted and the mean + s.d. calculated
and plotted as bar charts. R120G CRYAB was the only mutant sHSP that significantly increased the number of desmin aggregates in the transiently transfected cells.
Representatives of transfected cells are not shown. (d– f ). (d ) SW13 Vim2 cells were transiently co-transfected with desmin alone, (e) desmin and WT CRYAB and
( f ) desmin and R120G CRYAB. Note the aggregates in those cells co-transfected with desmin and R120G CRYAB. (g– i) The effect of the transient transfection of WT
CRYAB and R120G CRYAB upon the endogenous keratin networks in MCF7 cells. (g) MCF7 cells were transiently co-transfected with desmin alone, (h) desmin and
WT CRYAB and (i) desmin and R120G CRYAB. ( j– k) Transient transfection of MCF7 cells with R120G CRYAB. ( j ) Cells were then probed with both keratin and
(k) CRYAB antibodies. Note that in the R120G CRYAB transfected cells the endogenous keratin networks have collapsed around the nucleus, indicating the ability of
CRYAB R120G to act in a dominant negative fashion to aggregate keratin filaments. Scale bar, 10 mm.
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co-transfected with either the WT or mutant sHSP and the for-
mation of desmin aggregates compared with that of desmin
alone. The human cell line H36CE2 was chosen because it is
a human cell line that does not express desmin, but does
express vimentin. Lens epithelial cells can express desmin as
part of their response to posterior capsule opacification [103].
The results were recorded as the percentage of cells with
desmin-positive aggregates.
The transfection of desmin into H36CE2 cells leads to the
formation of desmin-positive aggregates in the cytoplasm of a
high proportion of the cells. Co-transfection with CRYAB sig-
nificantly reduced the incidence of aggregate-positive cells,
but when the R120G CRYAB was co-transfected with
desmin, this positive effect was lost and desmin aggregates
were once again apparent (figure 5a). In contrast, the co-
transfection of either HSP27 or R140G HSP27 (figure 5b) or
HSP16.2 or R95G HSP16.2 (figure 5c) all significantly reduced
desmin aggregate formation in transfected H36CE2 cells.
We selected two other cell lines to confirm the tendency of
R120G CRYAB to induce the aggregation of desmin filaments
in transiently transfected cells. In SW13/Cl2 Vim2 cells, an
adenocarcinoma cell line that lacks cytoplasmic intermediate
filaments, the transiently transfected desmin also failed to
form effective networks of desmin filament (figure 5d). Only
when co-transfected with WT CRYAB (figure 5e) were
desmin filament networks observed. As with H36CE2 cells,
co-transfection of desmin with R120G CRYAB induced
desmin filament aggregation (figure 5f ). These aggregates
costained with CRYAB antibodies (data not shown). A similar
experimental series is also shown for MCF7 cells, which have
an endogenous cytoplasmic keratin network, showing similar
results for co-transfection of WT and R120 CRYAB, albeit in
these cells desmin alonewas capable of forming a filament net-
work (figure 5g– i). The co-transfection of R120G CRYAB with
desmin caused the perinuclear collapse of the desmin fila-
ments (figure 5i). Interestingly, the transient transfection of
R120G CRYAB into MCF7 cells was also capable of causing
the collapse of the endogenous keratin network of filaments
(figure 5j,k), but there was no loss in cell viability.
In the course of these experiments involving MCF7 cells,
we noticed low transfection rates for the desmin when
co-transfected with R120G CRYAB. We therefore monitored
cell viability after transfection. We included a series of con-
trols including the DRM-causing desmin mutant A337P.
The results are presented in figure 6a. Co-transfection of
R120G CRYAB with WT desmin induced a significant
reduction in cell viability. This was not observed when
R120G CRYAB was transiently transfected into MCF7 cells.
R120G mergemito-DsRed
24 h
(b)
(e)(d)
(a)
1.0
0.8
0.6
ab
so
rb
an
ce
 (5
60
 nm
)
0.4
0.2
0
WTDes
A337PDes
R120G
– – –+ +
– + –– –
– – +– +
– – –+ +
– + –– –
– – +– +
48 h
50
42
33
27
50 desmin
CRYAB
actin
1
control
cleavage
2 3 4 5
42
33
27
C2
C1
2 +
 ST
S
De
s +
 Ca
spa
se-
6
pcD
NA
3
WT
De
s
WT
De
s+
R1
20
G
A3
37
PD
es
R1
20
G
(c)
Figure 6. Expression of mutant desmins reduces viability of MCF7 cells. (a) Cell viability was measured in MCF7 cells transiently transfected with WT desmin, A337P
desmin, R120G CRYAB alone or co-transfected with WT desmin and R120G CRYAB at a 1 : 1 molar ratio. Cells transfected with empty pcDNA3.1 vector were used as a
control. The viability of transfected MCF7 cells was determined at 24 and 48 h using the MTS-based cell viability assay. Data shown are the mean+ s.e. from three
independent experiments. Statistical significance was analysed by one-way ANOVA and the level of significance was set at p  0.05. (b) Desmin fragmentation by
caspases. Two desmin fragments (arrowheads) were generated in C2C12 cells induced to undergo apoptosis by treatment with 1 mM staurosporine (C2C12þ STS)
and in vitro by cleavage of purified desmin with active caspase 6 (Des þ Caspase 6). One of the proteolytic fragments was faintly observed in cells co-transfected
with WT desmin and R120G aB-crystallin (lane 3). Levels of protein expressed in transfected MCF7 cells were determined at 48 h after transfection. Immunoblotting
of total cell lysates and probing with antibodies to desmin, CRYAB and finally actin, as a loading control. (c– e) To determine the effect of expressing R120G CRYAB
(green channel) upon the distribution of mitochondria, MCF7 cells were transiently transfected with an IRES-containing bicistronic vector that allows simultaneously
expression of both mitochondrially targeted red fluorescent protein (c; red channel) and R120G CRYAB (d; green channel). Note the collapse of the mitochondria into
perinuclear locations in those cells (e; merged red and green channels) expressing R120G CRYAB.
rstb.royalsocietypublishing.org
PhilTransR
SocB
368:20120375
11
 on May 2, 2014rstb.royalsocietypublishing.orgDownloaded from 
Neither was the transfection of WT desmin deleterious for
cell viability. Interestingly, only the DRM-causing desmin
mutant A337P induced a similar reduction in cell viability.
These data suggest that DRM-causing mutations in either
desmin (A337P) or CRYAB (R120G) were capable of reducing
cell viability, but R120G CRYAB was dependent upon the
presence of desmin for this effect.
Desmin has been found to propagate the canonical apopto-
sis pathway, it being a substrate for caspase 6 [9] and evidenced
by our control experiments using staurosporin-treated C2C12
cells and caspase 6-treated desmin (figure 6b). Similar-sized
desmin proteolytic fragments were observed in samples pre-
pared from MCF7 cells transfected with A337P desmin and
for those co-transfected with the combination of WT desmin
and R120G CRYAB (figure 6b). Using the modified IRES-
Mito-DsRED-based pcDNA3.1 vector to identify the mitochon-
dria of transient transfected cells, R120G CRYAB induced the
collapse of mitochondria along with the perinuclear aggrega-
tion of the endogenous keratin filaments (figure 6c–e), but as
evidenced by the cell viability assay (see the electronic sup-
plementary material, figure S2) the expression of disease-
causing desmin mutants induces apoptosis by the activation
of caspases. The fact that R120G CRYAB induces the collapse
of the endogenous keratin filaments and the mitochondria in
MCF7 cells singly transfected with just R120G CRYAB is very
important especially as these are phenocopied by the co-trans-
fection of both R120G CRYAB with desmin. The important
difference is that only when R120G CRYAB is co-transfected
with WT desmin is there a significant decrease in cell viability,
which we take as prime fascia evidence of a unique and specific
interaction that sets it apart from keratins and vimentin, the
intermediate filaments found in H36CE2 and MCF7 cells.
( f ) CRYAB and desmin form a functional complex
The transient transfection studies suggest that desmin and
CRYAB are indeed a functional complex, which can deter-
mine whether transiently transfected cells continue to
proliferate or die (figure 6). Analysis of transgenic animal
models have tended to overlook the functional aspect of the
desmin-CRYAB interaction, focusing rather on the amyloid-
forming potential of R120G CRYAB [5], or on the ability of
R120G CRYAB [104,105] and desmin mutants [7] to inhibit
the proteosome or affect autophagy [8,38,106]. Our studies
illustrate that, while these are important consequences, the
primary lesion in the development of DRM appears to be
the dominant negative effect of the desmin–CRYAB complex
on cell viability. Indeed the effects of CRYAB on MCF7 cells
suggests that the only muscle-specific factors required in
order to precipitate the loss of viability is either a mutant
desmin, or R120G CRYAB in the presence of WT desmin.
This therefore suggests a very simple explanation for why
R120G CRYAB induces a myopathy and not, for instance, a
neuropathy, as muscle is the tissue where there is significant
expression of desmin, the intermediate filament partner
needed to trigger cell death and the muscle pathology
[9,18]. Indeed our data also suggest that aggregation of the
resident keratin intermediate filament network by R120G
CRYAB and the concentration of the mitochondria in a peri-
nuclear region are insufficient triggers for this loss in MCF7
viability. The fact that mutations in either desmin [2] or
CRYAB [1] phenocopy each other further evidences this key
functional link, which we suggest is fundamental to the
muscle pathologies associated with the respective mutations
in CRYAB and desmin. We conclude that the specific inter-
mediate filament expression pattern must be considered as
a key factor in any sHSP-based pathology and this study
is further evidence of the functional importance of the
sHSP-intermediate filament protein complex [41,42].
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